Denmark
QNTM Labs®, operating under the slogan "Innovative Laboratory Analytics," is a dynamic player in the biotechnology, industrial, and pharmaceutical sectors. Founded in 2020 and headquartered in Odense, Denmark, the company has rapidly positioned itself as a leader in contract laboratory services.
Specializing in chemical and biological analysis, QNTM Labs® excels in offering contract research, development, and regulatory compliance applications to pharmaceutical firms. The company's core mission is to innovate analytical methods and uphold the highest quality standards, aiming to redefine industry benchmarks. As global demand for quality data amplifies, QNTM Labs® is committed to enhancing transparency and accessibility in scientific analysis for global pharmaceutical stakeholders.
The company secured a Series A investment on 01 November 2022 from Intrinsic Capital Partners, signifying investor confidence in its growth trajectory and reinforcing its strategic importance to the industry.
